New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls.
Read the Q3 2026 report
Friday, Nov 20, 2026
Export LLY’s income statement to Excel — free account
Eli Lilly and Company
LLYHealthcare Drug Manufacturers General
Eli Lilly and Company’s revenue for fiscal 2025 (year ended December 2025) was $65.2 billion, up 44.7% from fiscal 2024.
- Revenue
- +38.6%
- EPS
- +16.3%
- Free cash flow
- +21.8%
- Total debt
- +15.0%
Quarter to September 2026, against a year earlier
1,352.05
0.40
+0.03%
Follow LLY
Alert me
Where the cash went Fiscal 2025, year to Dec 31, 2025
Dividends and buybacks of $9.5B were more than free cash flow of $9.0B; $8.1B of new borrowing made up the difference. Cash rose by $4.0B. What is a cash flow statement?
- Free cash flow
- $9.0B 53.4% of operating cash flow
- Returned to shareholders
- $9.5B 105.8% of free cash flow
- Debt, net
- $8.1B borrowed
- Change in cash
- +$4.0B over the period
| Operating cash flow | 16.8 |
|---|---|
| Capital expenditures | −7.8 |
| Free cash flow | 9.0 |
| From investments, net | +0.3 |
| Dividends | −5.4 |
| Buybacks, net | −4.1 |
| Debt raised, net | +8.1 |
| Other | −3.9 |
| Change in cash | 4.0 |
Free cash flow
| FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $4.9B | $5.6B | $5.5B | $4.8B | $6.5B | $7.4B | $7.6B | $4.2B | $8.8B | $16.8B |
| Capex | −$964M | −$1.1B | −$1.2B | −$1.0B | −$1.4B | −$1.3B | −$1.9B | −$3.4B | −$5.1B | −$7.8B |
| Free cash flow | $3.9B | $4.5B | $4.3B | $3.8B | $5.1B | $6.1B | $5.7B | $792M | $3.8B | $9.0B |
Figures in billions of dollars. Free cash flow is operating cash flow less capital expenditures. Investments are purchases less sales of securities; “Other” is what the named lines leave of the change in cash.
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
Net Income |
2,737.60 | (204.10) | 3,232.00 | 8,318.40 | 6,193.70 | 5,581.70 | 6,244.80 | 5,240.00 | 10,590.00 | 20,640.00 |
Depreciation & Amortization |
1,496.60 | 1,567.30 | 1,609.00 | 1,232.60 | 1,323.90 | 1,547.60 | 1,522.50 | 1,527.00 | 1,767.00 | 1,997.00 |
Non Cash Items (Other) |
1,100.90 | 1,047.50 | 3,062.20 | (3,027.20) | (270.60) | 1,249.20 | (180.80) | 528.00 | 1,845.00 | 2,269.00 |
Accounts Receivable Change |
(709.40) | (357.00) | (996.70) | (127.20) | (1,350.20) | (1,278.30) | (299.60) | (2,451.00) | (2,155.00) | (7,000.00) |
Change in inventories |
(328.20) | (253.90) | 7.80 | (258.70) | (533.40) | (235.90) | (599.70) | (1,425.00) | (2,507.00) | (4,671.00) |
Accounts Payable Change |
1,123.80 | 916.30 | (284.50) | (477.70) | 1,271.30 | (1,013.80) | 1,692.00 | 4,274.00 | 2,609.00 | 10,187.00 |
Income tax paid |
(304.80) | 3,489.60 | (125.30) | (221.30) | 322.00 | (359.70) | 346.60 | — | — | — |
Change in other assets and liabilities |
(265.50) | (590.10) | (980.00) | (602.30) | (457.10) | 1,515.40 | (793.50) | (3,453.00) | (3,331.00) | (6,609.00) |
Operating Cash Flow |
4,851.00 | 5,615.60 | 5,524.50 | 4,836.60 | 6,499.60 | 7,365.90 | 7,585.70 | 4,240.00 | 8,818.00 | 16,813.00 |
Capital expenditures |
(963.60) | (1,076.80) | (1,210.60) | (1,033.90) | (1,387.90) | (1,309.80) | (1,854.30) | (3,448.00) | (5,058.00) | (7,841.00) |
Net Aquisitions |
(45.00) | (882.10) | — | (6,562.90) | (849.30) | (747.40) | (327.20) | — | (947.70) | — |
Short Term Investments Change (Net) |
314.60 | 1,462.80 | 2,440.30 | 93.90 | 118.30 | (36.10) | 14.00 | 94.00 | 50.40 | — |
Long-Term Investments Change (Net) |
(2,260.00) | (2,025.60) | 2,671.60 | 362.30 | 398.40 | (129.90) | (258.00) | (223.00) | (303.00) | 319.00 |
Other investing activities |
(185.10) | (1,261.90) | (1,995.30) | (942.30) | (538.40) | (644.30) | (1,337.40) | (3,482.00) | (3,941.00) | (3,450.00) |
Investing cash flow |
(3,139.10) | (3,783.60) | 1,906.00 | (8,082.90) | (2,258.90) | (2,867.50) | (3,762.90) | (7,153.00) | (9,302.00) | (10,972.00) |
Repayment/Issuance of Debt (Net) |
2,499.60 | 2,998.90 | (729.30) | 4,685.40 | 291.60 | 501.40 | (62.00) | 8,650.00 | 8,901.00 | 8,051.00 |
Equity Repurchase (Common, Net) |
(600.10) | (299.80) | (2,491.00) | (4,400.00) | (500.00) | (1,250.00) | (1,500.00) | (750.00) | (2,500.00) | (4,108.00) |
Dividends Paid (Total) |
(2,158.50) | (2,192.10) | (2,311.80) | (2,409.80) | (2,687.10) | (3,086.80) | (3,535.80) | (4,069.00) | (4,680.00) | (5,384.00) |
Other financial activities |
(300.80) | (364.40) | (372.80) | (200.10) | (241.60) | (295.90) | (308.90) | (335.00) | (491.00) | (772.00) |
Financing cash flow |
(559.80) | 142.60 | (5,904.90) | (2,324.50) | (3,137.10) | (4,131.30) | (5,406.70) | 3,496.00 | 1,230.00 | (2,213.00) |
Exchange Rate Adjustment |
(236.40) | (20.50) | (63.60) | (89.90) | 216.00 | (205.70) | (167.60) | 169.00 | (297.00) | 372.00 |
Change in Cash |
915.70 | 1,954.10 | 1,462.00 | (5,660.70) | 1,319.60 | 161.40 | (1,751.50) | 752.00 | 449.00 | 4,000.00 |
Beginning Cash |
3,666.40 | 4,582.10 | 6,536.20 | 7,998.20 | 2,337.50 | 3,657.10 | 3,818.50 | 2,067.00 | 2,819.00 | 3,268.00 |
Ending Cash |
4,582.10 | 6,536.20 | 7,998.20 | 2,337.50 | 3,657.10 | 3,818.50 | 2,067.00 | 2,819.00 | 3,268.00 | 7,268.00 |
Stock Based Compensation |
255.30 | 281.30 | 279.50 | 312.40 | 308.10 | 342.80 | 371.10 | 629.00 | 646.00 | 626.00 |
Dividends Paid (Common) |
(2,158.50) | (2,192.10) | (2,311.80) | (2,409.80) | (2,687.10) | (3,086.80) | (3,535.80) | (4,069.00) | (4,680.00) | (5,384.00) |
Net Cash/Marketcap |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Assets Liabilities Change (Total) |
(484.10) | 3,204.90 | (2,378.70) | (1,687.20) | (747.40) | (1,012.60) | (0.80) | (3,055.00) | (5,384.00) | (8,093.00) |
Investments Change (Net) |
(1,945.40) | (562.80) | 5,111.90 | 456.20 | 516.70 | (166.00) | (244.00) | (223.00) | (303.00) | 319.00 |
Issuance/Purchase of Shares |
(600.10) | (299.80) | (2,491.00) | (4,400.00) | (500.00) | (1,250.00) | (1,500.00) | (750.00) | (2,500.00) | (4,108.00) |
| Other line items | ||||||||||
Revenue per Employee |
0.51 | 0.49 | 0.56 | 0.66 | 0.70 | 0.81 | 0.73 | 0.79 | 0.96 | 1.30 |
In millions of $ except per-share values · columns are period end dates · fundamentals updated Nov 18, 2026